Avalyn 药 AVLN
$29.15 +$2.48 (+9.30%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $29.15 0.00%
开盘$26.71
昨收$26.67
当日区间$26.13 – $29.18
成交量630.3K
市值$1.29B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$31.29M-43.7% YoY
净利润-$28.94M-43.3% YoY
摊薄每股收益-$0.65-35.2% YoY
自由现金流-$26.35M-27.3% YoY
经营现金流-$26.08M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
净资产收益率-25.9%
资产收益率-24.3%
投入资本回报率-26.6%
流动比率33.12
负债/资产比率6.4%
现金及投资$352.43M
总负债$16.29M
净现金（净负债）$336.13M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 归属普通股股东净利润 | -$28.94M | -$26.87M | -$85.20M | -$20.19M | -$17.50M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $31.29M | $27.91M | $91.29M | $21.78M | $18.72M |
| 非经营性利息支出 | $272,000.00 | $98,000.00 | – | $0.00 | $0.00 |
| 销售及管理费用 | $6.56M | $5.02M | $14.68M | $3.90M | $3.40M |
| -管理费用 | $6.56M | $5.02M | $14.68M | $3.90M | $3.40M |
| 摊薄每股收益 | -$0.65 | -$0.64 | -$2.04 | -$0.48 | -$0.42 |
| 基本每股收益 | -$0.65 | -$0.64 | -$2.04 | -$0.48 | -$0.42 |
| 研发费用 | $24.73M | $22.89M | $76.61M | $17.88M | $15.32M |
| 营业利润 | -$31.29M | -$27.91M | -$91.29M | -$21.78M | -$18.72M |
| 非经营性利息净收入（支出） | $2.42M | $1.03M | $6.18M | $1.63M | $1.25M |
| 非经营性利息收入 | $2.70M | $1.13M | $6.18M | $1.63M | $1.25M |
| 其他收入（支出） | -$69,000.00 | $13,000.00 | -$89,000.00 | -$41,000.00 | -$35,000.00 |
| 税前利润 | -$28.94M | -$26.87M | -$85.20M | -$20.19M | -$17.50M |
| 净利润 | -$28.94M | -$26.87M | -$85.20M | -$20.19M | -$17.50M |
| 持续经营利润 | -$28.94M | -$26.87M | -$85.20M | -$20.19M | -$17.50M |
| 归属母公司净利润 | -$28.94M | -$26.87M | -$85.20M | -$20.19M | -$17.50M |
| 其他非经营性收入（支出） | -$69,000.00 | $13,000.00 | -$89,000.00 | -$41,000.00 | -$35,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| -累计折旧 | -$216,000.00 | -$117,000.00 | -$54,000.00 | -$12,000.00 |
| 投资及预付款 | $61.10M | – | $0.00 | $7.49M |
| -可供出售证券 | $61.10M | – | – | $7.49M |
| 其他非流动资产 | $3.01M | $3.00M | $3.00M | $2.55M |
| 负债合计 | $27.10M | $399.91M | $387.54M | $299.04M |
| 流动负债合计 | $10.81M | $11.79M | $14.09M | $8.74M |
| 应付款 | $2.65M | $3.15M | $3.76M | $2.28M |
| -应付账款 | $2.65M | $3.15M | $3.76M | $2.28M |
| 一年内应计费用 | $4.17M | $6.29M | $5.60M | $3.72M |
| -固定资产原值 | $3.56M | $2.79M | $2.38M | $106,000.00 |
| 固定资产净值 | $3.35M | $2.68M | $2.32M | $94,000.00 |
| 总资产 | $425.45M | $135.66M | $148.88M | $124.52M |
| 流动资产合计 | $357.99M | $129.99M | $143.56M | $114.39M |
| 现金及现金等价物与短期投资 | $352.43M | $123.13M | $138.36M | $110.63M |
| -现金及现金等价物 | $264.20M | $92.31M | $52.32M | $23.96M |
| -短期投资 | $88.23M | $30.82M | $86.04M | $86.67M |
| 应收款 | $1.67M | $253,000.00 | $537,000.00 | $591,000.00 |
| -应计应收利息 | $1.67M | $253,000.00 | $537,000.00 | $591,000.00 |
| 一年内递延资产 | $221,000.00 | $2.73M | – | – |
| 非流动资产合计 | $67.46M | $5.68M | $5.32M | $10.13M |
| 非流动负债合计 | $16.29M | $388.12M | $373.45M | $290.30M |
| 长期债务及融资租赁负债 | $16.29M | $15.90M | $1.23M | $0.00 |
| -长期债务 | $14.80M | $14.81M | – | – |
| -长期融资租赁负债 | $1.49M | $1.09M | $1.23M | $0.00 |
| 可转换优先证券 | $0.00 | $372.22M | $372.22M | $290.30M |
| 股东权益合计 | $398.35M | -$264.25M | -$238.66M | -$174.52M |
| 股东权益 | $398.35M | -$264.25M | -$238.66M | -$174.52M |
| 股本 | $67,000.00 | $24,000.00 | $24,000.00 | $5,000.00 |
| -普通股 | $67,000.00 | $24,000.00 | $24,000.00 | $5,000.00 |
| 资本公积 | $719.54M | $27.95M | $26.55M | $5.43M |
| 留存收益 | -$321.17M | -$292.23M | -$265.36M | -$180.16M |
| 短期债务及融资租赁负债 | $816,000.00 | $507,000.00 | $444,000.00 | – |
| -一年内到期融资租赁负债 | $816,000.00 | $507,000.00 | $444,000.00 | $0.00 |
| 不影响留存收益的损益 | -$95,000.00 | $12,000.00 | $134,000.00 | $202,000.00 |
| 预付资产 | $3.67M | $3.88M | $4.66M | $3.17M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 债务发行及偿还净额 | $0.00 | $15.00M | – | $0.00 | $0.00 |
| 持续经营筹资活动现金流净额 | $316.67M | $14.86M | $99.79M | $89.88M | $0.00 |
| 筹资活动现金流 | $316.67M | $14.86M | $99.79M | $89.88M | $0.00 |
| 固定资产购置及出售净额 | -$269,000.00 | -$318,000.00 | -$344,000.00 | $0.00 | -$8,000.00 |
| 持续经营投资活动现金流净额 | -$118.71M | $55.02M | $10.06M | -$36.69M | $24.12M |
| 投资活动现金流净额 | -$118.71M | $55.02M | $10.06M | -$36.69M | $24.12M |
| -其他流动负债变动 | -$122,000.00 | -$70,000.00 | -$7,000.00 | $0.00 | $0.00 |
| -其他流动资产变动 | -$12,000.00 | $0.00 | -$450,000.00 | $119,000.00 | $120,000.00 |
| -应付账款及应计费用变动 | -$172,000.00 | -$3.58M | $4.25M | -$1.01M | -$1.62M |
| -预付资产变动 | $316,000.00 | -$508,000.00 | -$1.19M | -$279,000.00 | -$265,000.00 |
| 营运资金变动 | $10,000.00 | -$4.16M | $2.61M | -$1.17M | -$1.77M |
| 股票期权行使所得 | $4,000.00 | $25,000.00 | $18,000.00 | $0.00 | $0.00 |
| 其他筹资费用净额 | -$4.18M | -$163,000.00 | -$594,000.00 | – | – |
| 期末现金余额 | $264.20M | $92.31M | $52.32M | $61.30M | $28.80M |
| 投资购置及出售净额 | -$118.44M | $55.34M | $10.40M | -$36.69M | $24.13M |
| 自由现金流 | -$26.35M | -$30.21M | -$81.83M | -$20.70M | -$19.28M |
| 期初现金余额 | $92.31M | $52.32M | $23.96M | $28.80M | $23.96M |
| 现金净变动 | $171.89M | $40.00M | $28.36M | $32.50M | $4.84M |
| 其他非现金项目 | $129,000.00 | $114,000.00 | $146,000.00 | – | – |
| 折旧、折耗与摊销 | $110,000.00 | $63,000.00 | $42,000.00 | $9,000.00 | $10,000.00 |
| 经营活动现金流 | -$26.08M | -$29.89M | -$81.48M | -$20.70M | -$19.28M |
| 持续经营经营活动现金流净额 | -$26.08M | -$29.89M | -$81.48M | -$20.70M | -$19.28M |
| 持续经营净利润 | -$28.94M | -$26.87M | -$85.20M | -$20.19M | -$17.50M |
| 优先股发行净额 | – | – | $100.36M | – | – |
暂无评论——快来第一个聊聊 AVLN。
登录后参与讨论。